featured
ASCO Guideline Update on Chemotherapy and Targeted Therapy for Patients With Endocrine-Pretreated or HR− MBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor-Negative Metastatic Breast Cancer: ASCO Guideline Rapid Recommendation Update
J. Clin. Oncol 2023 Jan 10;[EPub Ahead of Print], B Moy, RB Rumble, LA CareyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.